FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282912982> ?p ?o ?g. }

• W4282912982 endingPage "41" @default.
• W4282912982 startingPage "34" @default.
• W4282912982 abstract "We retrospectively studied 125 patients with acute myeloid leukemia and trisomy 4 (median age at diagnosis, 58 years; range, 16-77 years) treated between 2000 and 2019 within a multicenter study. Trisomy 4 was the sole abnormality in 28 (22%) patients and additional abnormalities were present in 97 (78%) patients. Twenty-two (22%) and 15 (15%) of 101 tested patients harbored NPM1 and FLT3-ITD mutations. Two (3%) of 72 tested patients had double CEBPA mutations. Data on response to intensive anthracycline-based induction therapy were available for 119 patients. Complete remission was achieved in 67% (n=80) and the early death rate was 5% (n=6). Notably, patients with trisomy 4 as sole abnormality had a complete remission rate of 89%. Allogeneic hematopoietic cell transplantation was performed in 40 (34%) patients, of whom 19 were transplanted in first complete remission. The median follow-up of the intensively treated cohort was 5.76 years (95% confidence interval [95% CI]: 2.99-7.61 years). The 5-year overall survival and relapse-free survival rates were 30% (95% CI: 22-41%) and 27% (95% CI: 18-41%), respectively. An Andersen-Gill regression model on overall survival revealed that favorable-risk according to the European LeukemiaNet classification (hazard ratio [HR]=0.34; P=0.006) and trisomy 4 as sole abnormality (HR=0.41; P=0.01) were favorable factors, whereas age with a difference of 10 years (HR=1.15; P=0.11), female gender (HR=0.74; P=0.20) and allogeneic hematopoietic cell transplantation (HR=0.64; P=0.14) did not have an significant impact. In our cohort, patients with trisomy 4 as their sole abnormality had a high complete remission rate and favorable clinical outcome. Allogeneic hematopoietic cell transplantation did not seem to improve overall survival." @default.
• W4282912982 created "2022-06-16" @default.
• W4282912982 creator A5000841982 @default.
• W4282912982 creator A5003682435 @default.
• W4282912982 creator A5006122560 @default.
• W4282912982 creator A5008493103 @default.
• W4282912982 creator A5011914281 @default.
• W4282912982 creator A5016360607 @default.
• W4282912982 creator A5018356664 @default.
• W4282912982 creator A5018576827 @default.
• W4282912982 creator A5022644839 @default.
• W4282912982 creator A5025165056 @default.
• W4282912982 creator A5026359397 @default.
• W4282912982 creator A5026849709 @default.
• W4282912982 creator A5026905294 @default.
• W4282912982 creator A5028388949 @default.
• W4282912982 creator A5030035319 @default.
• W4282912982 creator A5030067333 @default.
• W4282912982 creator A5032225567 @default.
• W4282912982 creator A5034182883 @default.
• W4282912982 creator A5035426042 @default.
• W4282912982 creator A5036778361 @default.
• W4282912982 creator A5038634249 @default.
• W4282912982 creator A5039154800 @default.
• W4282912982 creator A5042951988 @default.
• W4282912982 creator A5043928512 @default.
• W4282912982 creator A5045850647 @default.
• W4282912982 creator A5047134346 @default.
• W4282912982 creator A5047829491 @default.
• W4282912982 creator A5051446836 @default.
• W4282912982 creator A5052619425 @default.
• W4282912982 creator A5053949970 @default.
• W4282912982 creator A5054393582 @default.
• W4282912982 creator A5061229750 @default.
• W4282912982 creator A5061797830 @default.
• W4282912982 creator A5067574718 @default.
• W4282912982 creator A5069478750 @default.
• W4282912982 creator A5069689988 @default.
• W4282912982 creator A5070722017 @default.
• W4282912982 creator A5071523133 @default.
• W4282912982 creator A5077114559 @default.
• W4282912982 creator A5079124367 @default.
• W4282912982 creator A5079605019 @default.
• W4282912982 creator A5085969689 @default.
• W4282912982 creator A5086016311 @default.
• W4282912982 creator A5088528119 @default.
• W4282912982 creator A5089694123 @default.
• W4282912982 creator A5090648381 @default.
• W4282912982 creator A5090795046 @default.
• W4282912982 date "2022-06-09" @default.
• W4282912982 modified "2023-10-18" @default.
• W4282912982 title "Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4" @default.
• W4282912982 cites W1539068276 @default.
• W4282912982 cites W1971056717 @default.
• W4282912982 cites W1971211622 @default.
• W4282912982 cites W1986705681 @default.
• W4282912982 cites W2022686977 @default.
• W4282912982 cites W2065464763 @default.
• W4282912982 cites W2073140442 @default.
• W4282912982 cites W2083575657 @default.
• W4282912982 cites W2092204146 @default.
• W4282912982 cites W2106234158 @default.
• W4282912982 cites W2112414163 @default.
• W4282912982 cites W2117446917 @default.
• W4282912982 cites W2118693086 @default.
• W4282912982 cites W2122834334 @default.
• W4282912982 cites W2132912591 @default.
• W4282912982 cites W2143995560 @default.
• W4282912982 cites W2144395887 @default.
• W4282912982 cites W2150113701 @default.
• W4282912982 cites W2159507916 @default.
• W4282912982 cites W2472925646 @default.
• W4282912982 cites W2483112829 @default.
• W4282912982 cites W2518336885 @default.
• W4282912982 cites W2559537906 @default.
• W4282912982 cites W2585690815 @default.
• W4282912982 cites W2715749014 @default.
• W4282912982 cites W2725930552 @default.
• W4282912982 cites W2792029111 @default.
• W4282912982 cites W2806682325 @default.
• W4282912982 cites W2970374115 @default.
• W4282912982 cites W3128365485 @default.
• W4282912982 cites W4293241248 @default.
• W4282912982 cites W4376595466 @default.
• W4282912982 doi "https://doi.org/10.3324/haematol.2022.281137" @default.
• W4282912982 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35678031" @default.
• W4282912982 hasPublicationYear "2022" @default.
• W4282912982 type Work @default.
• W4282912982 citedByCount "2" @default.
• W4282912982 countsByYear W42829129822023 @default.
• W4282912982 crossrefType "journal-article" @default.
• W4282912982 hasAuthorship W4282912982A5000841982 @default.
• W4282912982 hasAuthorship W4282912982A5003682435 @default.
• W4282912982 hasAuthorship W4282912982A5006122560 @default.
• W4282912982 hasAuthorship W4282912982A5008493103 @default.
• W4282912982 hasAuthorship W4282912982A5011914281 @default.
• W4282912982 hasAuthorship W4282912982A5016360607 @default.
• W4282912982 hasAuthorship W4282912982A5018356664 @default.

• next